| Industry Range | | Price / Earnings | N/A | |
| Book Value | 7.16 | |
| Earnings Per Share | -$0.80 | |
| Price To Sales Ratio | 34.84 | |
| Price To Book Ratio | 19.78 | |
| Price To Tangible Book Ratio | 20.56 | |
| Price/Cash Flow Ratio | N/A | |
| Price/Free Cash Flow Ratio | N/A | |
| Industry Range | | Market Capitalization | 5.7B | |
| Float (MRQ) | 73.99% | |
| Shares Outstanding (MRQ) | 113.0M | |
| Short Interest as a % of Float (MRQ) | 6.11% | |
| Shares Held By Institutions (MRQ) | 77.9M | |
| Industry Range | | Sales | $499.2M | |
| Gross Margin | 81.35% | |
| Net Profit Margin | -17.85% | |
| EBIT Margin | -16.95% | |
| EBITDA Margin | -10.99% | |
| Operating Margins | -16.95% | |
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K
statement or press releases. MRQ = Most Recent Quarter
| Industry Range | | Current Ratio (MRQ) | 6.77 | |
| Quick Ratio (MRQ) | 6.23 | |
| Total Debt/Equity Ratio (MRQ) | 12.54 | |
| Debt/Common Equity Ratio (MRQ) | 12.54 | |
| Industry Range | | Return on Equity | -11.10% | |
| Return on Assets | -12.09% | |
| Asset Turnover | 0.68 | |
| Receivables Turnover | 6.66 | |
| Inventory Turnover | 1.70 | |
| Industry Range | | EPS Growth Annual | N/A | |
| Dividend Yield 5 Year Average | 0.00% | |
| Current Dividend Yield | 0.00% | |
| Current Payout Ratio | N/A | |
*TXG does not pay a dividend. The average dividend yield for companies in the Biotechnology industry is 1.51%